122 related articles for article (PubMed ID: 1512146)
1. Quantitative comparison of radiolabeled antibody therapy and external beam radiotherapy in the treatment of human glioma xenografts.
Williams JA; Edwards JA; Dillehay LE
Int J Radiat Oncol Biol Phys; 1992; 24(1):111-7. PubMed ID: 1512146
[TBL] [Abstract][Full Text] [Related]
2. Radiobiologic studies of radioimmunotherapy and external beam radiotherapy in vitro and in vivo in human renal cell carcinoma xenografts.
Ning S; Trisler K; Wessels BW; Knox SJ
Cancer; 1997 Dec; 80(12 Suppl):2519-28. PubMed ID: 9406705
[TBL] [Abstract][Full Text] [Related]
3. Protracted exposure radiosensitization of experimental human malignant glioma.
Williams JA; Williams JR; Yuan X; Dillehay LE
Radiat Oncol Investig; 1998; 6(6):255-63. PubMed ID: 9885941
[TBL] [Abstract][Full Text] [Related]
4. Comparison of radioimmunotherapy and external beam radiotherapy in colon cancer xenografts.
Buras RR; Wong JY; Kuhn JA; Beatty BG; Williams LE; Wanek PM; Beatty JD
Int J Radiat Oncol Biol Phys; 1993 Feb; 25(3):473-9. PubMed ID: 8436526
[TBL] [Abstract][Full Text] [Related]
5. 131I radioimmunotherapy and fractionated external beam radiotherapy: comparative effectiveness in a human tumor xenograft.
Barendswaard EC; O'Donoghue JA; Larson SM; Tschmelitsch J; Welt S; Finn RD; Humm JL
J Nucl Med; 1999 Oct; 40(10):1764-8. PubMed ID: 10520720
[TBL] [Abstract][Full Text] [Related]
6. Targeting of human glioma xenografts in vivo utilizing radiolabeled antibodies.
Williams JA; Wessels BW; Wharam MD; Order SE; Wanek PM; Poggenburg JK; Klein JL
Int J Radiat Oncol Biol Phys; 1990 Jun; 18(6):1367-75. PubMed ID: 2370186
[TBL] [Abstract][Full Text] [Related]
7. Targeting and therapy of human glioma xenografts in vivo using radiolabeled antibodies.
Williams JA; Edwards JA; Wessels BW; Dillehay LE; Wanek PM; Poggenburg JK; Wharam MD; Order SE; Klein JL
Int J Radiat Oncol Biol Phys; 1990 Sep; 19(3):633-42. PubMed ID: 2170301
[TBL] [Abstract][Full Text] [Related]
8. Targeting and therapy of human glioma xenografts in vivo utilizing radiolabeled antibodies.
Williams JA; Wessels BW; Edwards JA; Kopher KA; Wanek PM; Wharam MD; Order SE; Klein JL
Cancer Res; 1990 Feb; 50(3 Suppl):974s-979s. PubMed ID: 2404587
[TBL] [Abstract][Full Text] [Related]
9. Reconciliation of tumor dose response to external beam radiotherapy versus radioimmunotherapy with 131iodine-labeled antibody for a colon cancer model.
Roberson PL; Buchsbaum DJ
Cancer Res; 1995 Dec; 55(23 Suppl):5811s-5816s. PubMed ID: 7493351
[TBL] [Abstract][Full Text] [Related]
10. Optimizing the sequence of combination therapy with radiolabeled antibodies and fractionated external beam.
Ruan S; O'Donoghue JA; Larson SM; Finn RD; Jungbluth A; Welt S; Humm JL
J Nucl Med; 2000 Nov; 41(11):1905-12. PubMed ID: 11079503
[TBL] [Abstract][Full Text] [Related]
11. Relative biologic effects of low-dose-rate alpha-emitting 227Th-rituximab and beta-emitting 90Y-tiuexetan-ibritumomab versus external beam X-radiation.
Dahle J; Bruland OS; Larsen RH
Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):186-92. PubMed ID: 18722269
[TBL] [Abstract][Full Text] [Related]
12. Implantable polymers for tirapazamine treatments of experimental intracranial malignant glioma.
Yuan X; Tabassi K; Williams JA
Radiat Oncol Investig; 1999; 7(4):218-30. PubMed ID: 10492162
[TBL] [Abstract][Full Text] [Related]
13. Fractionated radioimmunotherapy of human colon carcinoma xenografts with 131I-labeled monoclonal antibody CC49.
Buchsbaum D; Khazaeli MB; Liu T; Bright S; Richardson K; Jones M; Meredith R
Cancer Res; 1995 Dec; 55(23 Suppl):5881s-5887s. PubMed ID: 7493364
[TBL] [Abstract][Full Text] [Related]
14. Hyperfractionated and hypofractionated radiation therapy for human malignant glioma xenograft in nude mice.
Hasegawa M; Niibe H; Mitsuhashi N; Yamakawa M; Kato S; Furuta M; Kazumoto T; Hayakawa K; Nakazato Y
Jpn J Cancer Res; 1995 Sep; 86(9):879-84. PubMed ID: 7591967
[TBL] [Abstract][Full Text] [Related]
15. Combined radioimmunotherapy and radiotherapy of human colon carcinoma grafted in nude mice.
Buchegger F; Rojas A; Delaloye AB; Vogel CA; Mirimanoff RO; Coucke P; Sun LQ; Raimondi S; Denekamp J; Pèlgrin A
Cancer Res; 1995 Jan; 55(1):83-9. PubMed ID: 7805046
[TBL] [Abstract][Full Text] [Related]
16. Experimental radioimmunotherapy of a xenografted human glioma using 131I-labeled monoclonal antibody to epidermal growth factor receptor.
Takahashi H; Nakazawa S; Herlyn D
Neurol Med Chir (Tokyo); 1993 Sep; 33(9):610-5. PubMed ID: 7505399
[TBL] [Abstract][Full Text] [Related]
17. Tumor resection cavity administered iodine-131-labeled antitenascin 81C6 radioimmunotherapy in patients with malignant glioma: neuropathology aspects.
McLendon RE; Akabani G; Friedman HS; Reardon DA; Cleveland L; Cokgor I; Herndon JE; Wikstrand C; Boulton ST; Friedman AH; Bigner DD; Zalutsky MR
Nucl Med Biol; 2007 May; 34(4):405-13. PubMed ID: 17499730
[TBL] [Abstract][Full Text] [Related]
18. Comparison of multiple bolus and continuous injections of 131I-labeled CC49 for therapy in a colon cancer xenograft model.
Buchsbaum DJ; Khazaeli MB; Mayo MS; Roberson PL
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3153s-3159s. PubMed ID: 10541357
[TBL] [Abstract][Full Text] [Related]
19. The decreased influence of overall treatment time on the response of human breast tumor xenografts following prolongation of the potential doubling time (Tpot).
Sarkaria JN; Fowler JF; Lindstrom MJ; Jordan VC; Mulcahy RT
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(4):833-40. PubMed ID: 7860396
[TBL] [Abstract][Full Text] [Related]
20. Radiobiological comparison of external beam irradiation and radioimmunotherapy in renal cell carcinoma xenografts.
Wessels BW; Vessella RL; Palme DF; Berkopec JM; Smith GK; Bradley EW
Int J Radiat Oncol Biol Phys; 1989 Dec; 17(6):1257-63. PubMed ID: 2599909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
